Search results
Could This Drug News Lift AbbVie's Stock?
Motley Fool· 1 year agoConsider AbbVie's (NYSE: ABBV) crown jewel drug, Humira, which hauled in $21.2 billion in revenue in 2022. The good news is that AbbVie knew this day...
Better Growth Stock: Abbott vs. AbbVie
Motley Fool via Yahoo Finance· 4 months agoAbbott Laboratories (NYSE: ABT) and AbbVie (NYSE: ABBV) share a common past. About a decade ago, Abbott spun out its pharmaceuticals business into a...
AbbVie Stock Shows Rising Relative Strength Rating
Investor's Business Daily· 8 months agoOn Thursday, AbbVie stock got an upgrade to its Relative Strength (RS) Rating, from 68 to 71. See if AbbVie stock can continue to show renewed price...
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) both beat last year's bear market....
This Healthcare Stock Disappointed Investors. Here's Why It's Still a Buy.
Motley Fool· 2 years agoAbbVie (NYSE: ABBV) shares have been one of the bright spots in the stock market this year. All of...
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Investor's Business Daily· 4 weeks agoAbbVie stock has slumped 9% off its record high in March and is facing increasingly steep...
Is AbbVie Stock A Buy Or A Sell With Humira Rivals Looming?
Investor's Business Daily· 2 years agoAbbVie stock is under pressure after the company posted a mixed second-quarter report that relied...
Why Abbvie Stock Popped Today
Motley Fool· 6 months agoThe big asset buy in the healthcare industry provided a healthy pop to the two companies involved on Thursday. The stock price of the buyer, sector...
AbbVie Stock Is One To Watch As It Sees RS Rating Jump To 91
Investor's Business Daily· 2 years agoWhen looking for the best stocks to buy and watch, focus on those with rising relative price...
AbbVie's $21 Billion Drug Humira Is on the Decline. Should You Still Buy This Dividend Stock?
Motley Fool· 6 months agoFor the past couple of years, investors looked ahead to one particular thing with dread: AbbVie's...
